Atlas Trials

Catherine Bollard

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Catherine Bollard

RecordFirmDate
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 (NCT04975698)Catherine Bollard2021-10-25
Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP) (NCT04236479)Catherine Bollard2020-07-29
Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST) (NCT04248192)Catherine Bollard2020-05-01
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma (NCT03843294)Catherine Bollard2019-06-24
HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals (NCT03485963)Catherine Bollard2019-03-21
Multi-antigen T Cell Infusion Against Neuro-oncologic Disease (NCT03652545)Catherine Bollard2018-12-12
Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease (NCT02150551)Catherine Bollard2018-06-07
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis (NCT03594981)Catherine Bollard2018-01-24

Track Catherine Bollard automatically

Every clearance here is in the API, with alerts when new ones post.